Date Name Title Filing Type Shares Traded Price Total Held
Dec 17, 2007
VP & Gn Mgr Ind Ops & Prod Sup
VP & Gn Mgr Ind Ops & Prod Sup Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 40,000 -- 40,000
Sep 07, 2007
VP & Gn Mgr Ind Ops & Prod Sup
VP & Gn Mgr Ind Ops & Prod Sup Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 19,136 -- 19,136
Sep 07, 2007
VP & Gn Mgr Ind Ops & Prod Sup
VP & Gn Mgr Ind Ops & Prod Sup Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 60,864 -- 60,864
Oct 08, 2004
VP Clinical Programs
VP Clinical Programs Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 1,500 $7.44 12,030
Oct 08, 2004
VP Clinical Programs
VP Clinical Programs Form 4 Open market or private sale of non-derivative or derivative security 1,500 $8.10 10,530
Oct 08, 2004
VP Clinical Programs
VP Clinical Programs Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 1,500 $7.44 12,030
Oct 08, 2004
VP Clinical Programs
VP Clinical Programs Form 4 Open market or private sale of non-derivative or derivative security 1,500 $7.96 10,530
Oct 08, 2004
VP Clinical Programs
VP Clinical Programs Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 3,500 $7.44 14,030
Oct 08, 2004
VP Clinical Programs
VP Clinical Programs Form 4 Open market or private sale of non-derivative or derivative security 3,500 $7.96 10,530
Oct 08, 2004
VP Clinical Programs
VP Clinical Programs Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 8,000 $7.44 18,530

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.